INTRA CELLULAR THERAPIES INC shareholders Q3 2023

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

INTRA CELLULAR THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blume Capital Management, Inc. 1,250$65,1130.02%
TUDOR INVESTMENT CORP ET AL 36,279$1,889,7730.02%
AMERICAN CENTURY COMPANIES INC 441,410$22,993,0630.02%
ESSEX INVESTMENT MANAGEMENT CO LLC 2,109$109,8580.02%
LMR Partners LLP 31,200$1,625,2080.02%
Walleye Capital LLC 134,655$7,014,1790.02%
Orion Portfolio Solutions, LLC 27,298$1,421,9530.02%
PRINCIPAL FINANCIAL GROUP INC 416,002$21,669,5480.02%
JANUS HENDERSON GROUP PLC 480,273$25,014,4960.02%
AMERICAN INTERNATIONAL GROUP, INC. 46,764$2,435,9370.02%
Coppell Advisory Solutions LLC 891$47,1520.02%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 974,914$50,783,2700.02%
METROPOLITAN LIFE INSURANCE CO/NY 5,393$280,9210.02%
Hudson Bay Capital Management LP 70,000$3,646,3000.01%
State of Wyoming 1,264$65,8420.01%
ExodusPoint Capital Management, LP 28,660$1,4930.01%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 56,138$2,924,0000.01%
Nuveen Asset Management, LLC 713,261$37,153,7650.01%
SEI INVESTMENTS CO 137,841$7,180,2830.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 49,887$2,598,6140.01%
External links

This page lists INTRA CELLULAR THERAPIES INC's shareholders in Q3 2023. To view INTRA CELLULAR THERAPIES INC's shareholder history, click here.